(Q35841369)

10 August 2017

1 reference

title

Management of opportunistic infections in solid-organ transplantation (English)

1 reference

10 August 2017

main subject

organ transplantation

1 reference

based on heuristic

inferred from title

opportunistic infection

1 reference

Loretta M Chiu

1

1 reference

10 August 2017

Beata M Domagala

series ordinal

2

1 reference

10 August 2017

Jeong M Park

series ordinal

3

1 reference

10 August 2017

publication date

1 June 2004

1 reference

Progress in Transplantation: the journal for procurement and clinical transplant professionals

10 August 2017

published in

1 reference

10 August 2017

volume

14

1 reference

10 August 2017

issue

2

1 reference

10 August 2017

page(s)

114-129

1 reference

Infection in organ-transplant recipients

10 August 2017

cites work

1 reference

https://api.crossref.org/works/10.7182%2FPRTR.14.2.D8526452QT422V52

Clostridium difficile colitis after kidney and kidney-pancreas transplantation.

21 January 2018

1 reference

https://api.crossref.org/works/10.7182%2FPRTR.14.2.D8526452QT422V52

The challenge of vancomycin-resistant enterococci: a clinical and epidemiologic study.

21 January 2018

1 reference

https://api.crossref.org/works/10.7182%2FPRTR.14.2.D8526452QT422V52

Vancomycin-resistant enterococci: 15 years and counting

21 January 2018

1 reference

https://api.crossref.org/works/10.7182%2FPRTR.14.2.D8526452QT422V52

Clinical practice. Antibiotic-associated diarrhea

21 January 2018

1 reference

https://api.crossref.org/works/10.7182%2FPRTR.14.2.D8526452QT422V52

Adjunctive intracolonic vancomycin for severe Clostridium difficile colitis: case series and review of the literature

21 January 2018

1 reference

https://api.crossref.org/works/10.7182%2FPRTR.14.2.D8526452QT422V52

Infectious disease prophylaxis in renal transplant patients: a survey of US transplant centers

21 January 2018

1 reference

https://api.crossref.org/works/10.7182%2FPRTR.14.2.D8526452QT422V52

Tuberculosis in renal transplant recipients

21 January 2018

1 reference

https://api.crossref.org/works/10.7182%2FPRTR.14.2.D8526452QT422V52

Bioavailability of cyclosporine with concomitant rifampin administration is markedly less than predicted by hepatic enzyme induction

21 January 2018

1 reference

https://api.crossref.org/works/10.7182%2FPRTR.14.2.D8526452QT422V52

Fungal infections in solid-organ transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.7182%2FPRTR.14.2.D8526452QT422V52

Fungal infections in the recipients of solid organ transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.7182%2FPRTR.14.2.D8526452QT422V52

Randomized trial of fluconazole versus nystatin for the prophylaxis of Candida infection following liver transplantation.

21 January 2018

1 reference

https://api.crossref.org/works/10.7182%2FPRTR.14.2.D8526452QT422V52

Development of interpretive breakpoints for antifungal susceptibility testing: conceptual framework and analysis of in vitro-in vivo correlation data for fluconazole, itraconazole, and candida infections. Subcommittee on Antifungal Susceptibility Te

21 January 2018

1 reference

https://api.crossref.org/works/10.7182%2FPRTR.14.2.D8526452QT422V52

Comparison of caspofungin and amphotericin B for invasive candidiasis

21 January 2018

1 reference

https://api.crossref.org/works/10.7182%2FPRTR.14.2.D8526452QT422V52

A randomized and blinded multicenter trial of high-dose fluconazole plus placebo versus fluconazole plus amphotericin B as therapy for candidemia and its consequences in nonneutropenic subjects.

21 January 2018

1 reference

https://api.crossref.org/works/10.7182%2FPRTR.14.2.D8526452QT422V52

Epidemiology of fungal infections in solid organ transplant patients

21 January 2018

1 reference

https://api.crossref.org/works/10.7182%2FPRTR.14.2.D8526452QT422V52

Clinical significance of nephrotoxicity in patients treated with amphotericin B for suspected or proven aspergillosis

21 January 2018

1 reference

https://api.crossref.org/works/10.7182%2FPRTR.14.2.D8526452QT422V52

Practice guidelines for diseases caused by Aspergillus. Infectious Diseases Society of America

21 January 2018

1 reference

https://api.crossref.org/works/10.7182%2FPRTR.14.2.D8526452QT422V52

Effect of voriconazole on the pharmacokinetics of cyclosporine in renal transplant patients

21 January 2018

1 reference

https://api.crossref.org/works/10.7182%2FPRTR.14.2.D8526452QT422V52

Incidence of histoplasmosis following allogeneic bone marrow transplant or solid organ transplant in a hyperendemic area

21 January 2018

1 reference

https://api.crossref.org/works/10.7182%2FPRTR.14.2.D8526452QT422V52

Blastomycosis in transplant recipients: report of a case and review

21 January 2018

1 reference

https://api.crossref.org/works/10.7182%2FPRTR.14.2.D8526452QT422V52

Early results of targeted prophylaxis for coccidioidomycosis in patients undergoing orthotopic liver transplantation within an endemic area

21 January 2018

1 reference

https://api.crossref.org/works/10.7182%2FPRTR.14.2.D8526452QT422V52

Practice guideline for the treatment of coccidioidomycosis. Infectious Diseases Society of America

21 January 2018

1 reference

https://api.crossref.org/works/10.7182%2FPRTR.14.2.D8526452QT422V52

Prevention and treatment of cytomegalovirus infection in organ transplant recipients

21 January 2018

1 reference

https://api.crossref.org/works/10.7182%2FPRTR.14.2.D8526452QT422V52

Late and atypical cytomegalovirus disease in solid-organ transplant recipients

21 January 2018

1 reference

https://api.crossref.org/works/10.7182%2FPRTR.14.2.D8526452QT422V52

Prevention of infections in solid organ transplant recipients

21 January 2018

1 reference

https://api.crossref.org/works/10.7182%2FPRTR.14.2.D8526452QT422V52

Prevention of cytomegalovirus disease in recipients of solid-organ transplants

21 January 2018

1 reference

https://api.crossref.org/works/10.7182%2FPRTR.14.2.D8526452QT422V52

Valganciclovir results in improved oral absorption of ganciclovir in liver transplant recipients

21 January 2018

1 reference

https://api.crossref.org/works/10.7182%2FPRTR.14.2.D8526452QT422V52

Randomised trial of efficacy and safety of oral ganciclovir in the prevention of cytomegalovirus disease in liver-transplant recipients. The Oral Ganciclovir International Transplantation Study Group [corrected].

21 January 2018

1 reference

https://api.crossref.org/works/10.7182%2FPRTR.14.2.D8526452QT422V52

Valacyclovir for the prevention of cytomegalovirus disease after renal transplantation. International Valacyclovir Cytomegalovirus Prophylaxis Transplantation Study Group.

21 January 2018

1 reference

https://api.crossref.org/works/10.7182%2FPRTR.14.2.D8526452QT422V52

Infections in recipients of kidney transplants

21 January 2018

1 reference

https://api.crossref.org/works/10.7182%2FPRTR.14.2.D8526452QT422V52

Viral infections after renal transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.7182%2FPRTR.14.2.D8526452QT422V52

Attenuated varicella virus vaccine in children with renal transplants

21 January 2018

1 reference

https://api.crossref.org/works/10.7182%2FPRTR.14.2.D8526452QT422V52

Epstein-Barr virus-induced B-cell lymphoma after renal transplantation: acyclovir therapy and transition from polyclonal to monoclonal B-cell proliferation

21 January 2018

1 reference

https://api.crossref.org/works/10.7182%2FPRTR.14.2.D8526452QT422V52

Reduced incidence of Epstein-Barr virus-associated posttransplant lymphoproliferative disorder using preemptive antiviral therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.7182%2FPRTR.14.2.D8526452QT422V52

Comparison of intravenous ganciclovir followed by oral acyclovir with intravenous ganciclovir alone for prevention of cytomegalovirus and Epstein-Barr virus disease after liver transplantation in children

21 January 2018

1 reference

https://api.crossref.org/works/10.7182%2FPRTR.14.2.D8526452QT422V52

The role of antiviral and immunoglobulin therapy in the prevention of Epstein-Barr virus infection and post-transplant lymphoproliferative disease following solid organ transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.7182%2FPRTR.14.2.D8526452QT422V52

Human polyoma virus-associated interstitial nephritis in the allograft kidney

21 January 2018

1 reference

https://api.crossref.org/works/10.7182%2FPRTR.14.2.D8526452QT422V52

Immunosuppression and BKV Nephropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.7182%2FPRTR.14.2.D8526452QT422V52

BK virus in solid organ transplant recipients: an emerging syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.7182%2FPRTR.14.2.D8526452QT422V52

Quantitative viral load monitoring and cidofovir therapy for the management of BK virus-associated nephropathy in children and adults

21 January 2018

1 reference

https://api.crossref.org/works/10.7182%2FPRTR.14.2.D8526452QT422V52

Successful toxoplasmosis prophylaxis after orthotopic cardiac transplantation with trimethoprim-sulfamethoxazole

21 January 2018

1 reference

https://api.crossref.org/works/10.7182%2FPRTR.14.2.D8526452QT422V52

Prophylaxis strategies for solid-organ transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.7182%2FPRTR.14.2.D8526452QT422V52

10.7182/PRTR.14.2.D8526452QT422V52

21 January 2018

Identifiers

DOI

1 reference

10 August 2017

1 reference